| 产品详情 |
| Edit |   |
|---|
| Product Name | CCT241161 |
|---|
| Description | MW: 541.63. CCT241161, a pan-RAF/SFK inhibitor is active against treatment-naive BRAF and NRAS mutant tumors. It is active in tumors from patients who developed resistance to BRAF-selective inhibitors and a BRAF plus MEK inhibitor combination. IC50 0.03µM and 0.01µM for BRAF kinase and SRC kinase respectively. |
|---|
| Size | 10 mg |
|---|
| Concentration | n/a |
|---|
| Applications | RUO |
|---|
| Other Names | 1-(3-(tert-butyl)-1-phenyl-1H-pyrazol-5-yl)-3-(2-(methylthio)-4-((3-oxo-3,4-dihydropyrido[2,3-b]pyrazin-8-yl)oxy)phenyl)urea |
|---|
| Gene, Accession, CAS # | CAS: 1163719-91-2 |
|---|
| Catalog # | abx076819 |
|---|
| Price | |
|---|
| Order / More Info | CCT241161 from ABBEXA |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|